Earnings summaries and quarterly performance for AMBEV.
Executive leadership at AMBEV.
Board of directors at AMBEV.
Research analysts who have asked questions during AMBEV earnings calls.
Lucas Ferreira
JPMorgan Chase & Co.
4 questions for ABEV
Thiago Duarte
BTG Pactual
4 questions for ABEV
Isabella Simonato
Bank of America
3 questions for ABEV
Leonardo Alencar
XP Investimentos
3 questions for ABEV
Carlos Laboy
HSBC
2 questions for ABEV
Felipe Ucros Nunez
Scotiabank
2 questions for ABEV
Henrique Brustolin
Bradesco BBI
2 questions for ABEV
Ricardo Alves
Morgan Stanley
2 questions for ABEV
Guilherme Palhares
Santander
1 question for ABEV
Isabella Simonato Alonso
Bank of America Merrill Lynch
1 question for ABEV
Renata Cabral
Citigroup
1 question for ABEV
Renata Fonseca Cabral Sturani
Citibank
1 question for ABEV
Robert Ottenstein
Evercore ISI
1 question for ABEV
Rodrigo Alcantara
UBS
1 question for ABEV
Recent press releases and 8-K filings for ABEV.
- Ambev reported Q3 2025 EBITDA growth of 3% with 50 basis points of margin expansion and normalized EPS grew 8%, driven by 7% net revenue per hectoliter growth despite softer industry volumes in Brazil.
- The Board of Directors approved a $1 billion share buyback program on October 29, 2025, for canceling shares, and a new BRL2.5 billion buyback program is starting after the previous one completed in June.
- Year-to-date, the company's top line grew 4%, EBITDA was up over 7% with 120 basis points of margin expansion, and normalized EPS grew above 7%, supported by cost initiatives and disciplined management.
- Industry softness in Brazil was attributed to colder weather (approximately 70% of the decline) and constrained consumer purchasing power, but Ambev's premium and super premium brands continued to grow volumes by more than 9%.
- AMBEV S.A. has approved a share buyback program to repurchase up to 208,000,000 common shares.
- The program's primary purpose is share cancellation to maximize shareholder value and will be in effect until April 29, 2027.
- The company currently has 4,253,039,958 outstanding shares.
- The estimated cost for the maximum repurchase is approximately R$ 2,500,000,000.00, based on the October 29, 2024 closing share price, representing about 15% of the Company's cash.
- The acquisition will be recorded as a debit on the capital reserve from the September 30, 2025 balance sheet.
- Ambev reported 1.2% organic net revenue growth and 2.9% organic Normalized EBITDA growth for Q3 2025, with Normalized EBITDA margin expanding 50 bps to 33.9%.
- Consolidated volumes declined by 5.8% organically in Q3 2025, primarily due to soft industries in Brazil, Canada, and Latin America South.
- Normalized Profit for Q3 2025 increased by 7.4% to R$ 3,843.1 million, while cash flow from operating activities decreased by 14.7% compared to Q3 2024.
- The Board of Directors approved a R$ 2.5 billion share buyback program for up to 208,000,000 shares to be executed within the next 18 months.
- Ambev reported net income of R$4,863,720 thousand and basic earnings per share of R$0.3041 for the third quarter of 2025, with nine-month net income reaching R$11,458,935 thousand.
- The company completed the sale of 61.83% of its interest in SLU Beverages LTD. for US$115 million (R$612 million) on July 31, 2025, recognizing a gain of R$884 million related to the transaction.
- A dividend of R$0.1283 per share was approved on July 30, 2025, and paid on October 6, 2025.
- A new share buyback program was approved on October 29, 2025, authorizing the repurchase of up to 208,000,000 common shares until April 29, 2027.
- The effective tax rate for Q3 2025 was 6.72%, influenced by the SLU disposal and a R$375 million impact from the partial reversal of a tax liability.
Quarterly earnings call transcripts for AMBEV.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more
Let Fintool AI Agent track AMBEV's earnings for you
Get instant analysis when filings drop